Gaposchkin C G, Bilsky M H, Ginsberg R, Brennan M F
Division of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Neurosurgery. 1998 Jun;42(6):1297-301; discussion 1301-3. doi: 10.1097/00006123-199806000-00058.
Low-grade fibrosarcomas and desmoid tumors present a surgical challenge in that they have a strong tendency for local invasion, surgical margins are poorly delineated, and complete resections are difficult. Nowhere is this more evident than in those lesions involving the brachial plexus. We review our experience with these difficult lesions.
From a prospective database of 2900 patients admitted for treatment of sarcoma between 1982 and 1996, we identified 15 patients with involvement of the brachial plexus by a low-grade fibrosarcoma or desmoid tumor. All patients underwent resection, with 13 of 15 receiving adjuvant radiotherapy. The 15 patients had a mean age at initial operation of 47 years. The male-to-female ratio was 8:7. The mean follow-up period was 65 months (median, 53 mo).
Gross total resection was achieved in 12 patients (80%), although 11 of these patients had positive surgical margins. Overall, 64% of the tumors have recurred locally. There were no distant metastases, and no patients died as a result of their disease. One patient died as a result of unrelated cancer. An assessment of the functional outcomes revealed seven patients with normal function or mild neurological deficits and eight who were suffering from significant weakness, debilitation, or chronic pain. One patient required forequarter amputation.
Surgical resection plus postoperative radiotherapy is the treatment of choice for low-grade fibrosarcomas and desmoid tumors involving the brachial plexus. However, aggressive surgical management with the goal of achieving a gross total resection with negative histological margins can produce unnecessary morbidity. Preserving function should be a primary goal of the operations, although this will be associated with residual disease and will risk local recurrence but rarely death resulting from the disease.
低度恶性纤维肉瘤和硬纤维瘤在手术方面具有挑战性,因为它们具有很强的局部侵袭倾向,手术切缘难以界定,完整切除困难。这在涉及臂丛神经的病变中最为明显。我们回顾了我们处理这些疑难病变的经验。
从1982年至1996年间收治肉瘤患者的2900例前瞻性数据库中,我们确定了15例臂丛神经受低度恶性纤维肉瘤或硬纤维瘤侵犯的患者。所有患者均接受了手术切除,15例中有13例接受了辅助放疗。15例患者初次手术时的平均年龄为47岁。男女比例为8:7。平均随访期为65个月(中位数为53个月)。
12例患者(80%)实现了肉眼下全切,尽管其中11例患者手术切缘阳性。总体而言,64%的肿瘤出现了局部复发。无远处转移,也没有患者因疾病死亡。1例患者因 unrelated cancer 死亡。对功能结果的评估显示,7例患者功能正常或有轻度神经功能缺损,8例患者有明显的无力、衰弱或慢性疼痛。1例患者需要进行上肢截肢。
手术切除加术后放疗是治疗累及臂丛神经的低度恶性纤维肉瘤和硬纤维瘤的首选方法。然而,以实现组织学切缘阴性的肉眼下全切为目标的积极手术治疗可能会产生不必要的发病率。保留功能应是手术的主要目标,尽管这会伴有残留疾病并存在局部复发风险,但很少导致因疾病死亡。